Ridgeback Capital Investments
Overview
Ridgeback Capital Investments is a private equity firm specializing in healthcare investments, focusing on life-saving and life-changing therapies. The firm invests in both private and public companies dedicated to the development of transformative medicines and technologies. Founded in 2006 by Dr. Wayne Holman, Ridgeback Capital has a track record of supporting innovative companies in the biotechnology and pharmaceutical sectors. The firm's investment strategy emphasizes patient capital, recognizing that healthcare advancements often require long-term commitment. Ridgeback Capital seeks to partner with companies that are creating life-saving and life-changing technologies, providing the necessary support to bring these innovations to market. The firm has been involved in various stages of investment, including seed, early-stage, late-stage venture, growth, and buyouts. Ridgeback Capital's portfolio includes a diverse range of healthcare companies, from emerging biotechs to established players. The firm's strategic investments reflect its commitment to driving growth and innovation in the healthcare sector, aiming to make a significant impact on global health through its support of pioneering companies and therapies.
Investment Focus
- Focus on life-saving and life-changing therapies
- Commitment to long-term growth
- Innovative technologies in biotechnology and pharmaceuticals
Portfolio Companies
Reach Ridgeback Capital Investments directly
Verified work email, phone and LinkedIn for the full team — one spreadsheet, one payment, yours to keep.
Unlock full contacts →Frequently asked questions about Ridgeback Capital Investments
What sectors does Ridgeback Capital Investments invest in?
Ridgeback Capital Investments invests in Healthcare, Education, Health Care, Life Sciences, Pharmaceuticals and Biotechnology, and is based in Florida, United States. Ridgeback Capital Investments is listed as a private equity in the ConnectSafely investor database.
What stage does Ridgeback Capital Investments invest at?
Ridgeback Capital Investments backs companies at Seed, Early Stage, Growth and Buyout.
Which regions does Ridgeback Capital Investments invest in?
Ridgeback Capital Investments invests across United States.
What companies has Ridgeback Capital Investments invested in?
Ridgeback Capital Investments's portfolio includes Vertex Pharmaceuticals, LENZ Therapeutics, Gilead Sciences, Turnstone Biologics, Caribou Biosciences, 4D Molecular Therapeutics, Senti Biosciences and Intercept Pharmaceuticals.
Last updated · Source: ConnectSafely investor database
